Treating patients with "thin" endometrium - an ongoing challenge

Oshrit Lebovitz, Raoul Orvieto
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2014 · vol. 30(6) , pp. 409–414 · doi:10.3109/09513590.2014.906571 · PMID:24693854 · W2105862746
Review OA: closed CC0 ⤵ 20 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This literature review examined treatments for "thin" endometrium, finding that current modalities offer only minor improvements in thickness and pregnancy rates, highlighting the need for further research.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To review the literature regarding inadequate growth ("thin") of the endometrium and to present the hitherto published methods aimed to improve endometrial thickness and the consequent endometrial receptivity. MATERIALS AND METHODS: A literature review was conducted for all relevant articles assessing the effect of various treatment modalities on "thin" endometrium and the consequent reproductive outcome. RESULTS: Several treatment modalities have been offered to patients with "thin" endometrium, including hysteroscopic adhesiolysis, hormonal manipulation by estrogen and GnRH-agonist, vasoactive measures such as aspirin, vitamin E, pentoxifylline, l-arginine or sildenafil, intra-uterine infusion of growth factor such as G-CSF and the recent application of regenerative medicine. In spite of the vast diversity of treatment, most of the options accomplish only minor change in the endometrium thickness and subsequent pregnancy rate, and when they fail, patients are usually referred to surrogacy. CONCLUSIONS: "Thin" endometrium is known to adversely affect reproductive performance. Treatment of "thin endometrium" remains a challenge and future large researches are required to further elucidate and optimal management of patients with "thin" endometrium.

My notes (saved in your browser only)

MeSH descriptors

Endometrium Infertility, Female Uterine Diseases Combined Modality Therapy Drug Resistance, Multiple Endometrium Endometrium Endometrium Female Fertility Agents, Female Fertility Agents, Female Humans Infertility, Female Infertility, Female Uterine Diseases Uterine Diseases Uterine Diseases Uterine Diseases Vasodilator Agents Vasodilator Agents

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (76)

Cited by (16)

Source provenance

openalex
last seen: 2026-05-11T06:01:13.017405+00:00
pubmed
last seen: 2026-10-08T21:13:27.857801+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: CC0 · commercial use OK